LightMD Inc

LightMD Inc manufactures FDA-approved photobiomodulation (PBM) therapy systems utilizing low-level LED light technology for non-invasive therapeutic applications. The company specializes in light therapy devices designed for deep tissue and whole-organ penetration, treating symptomatic relief of pain conditions including back pain, joint pain, neck pain, sprains, strains, and arthritis. Their flagship product, the Mark II System, delivers uniformly distributed light across large treatment areas via 200 high-quality LEDs per flexible LightPad, offering the highest light output density claimed in their market segment. The technology operates on specific non-ionizing wavelengths to stimulate cellular functions without drugs or invasive procedures. LightMD's PBM therapy has been documented in peer-reviewed literature for symptomatic COVID-19 treatment and supported by over 2,500 clinical studies demonstrating infrared photo biostimulation efficacy. The company markets to medical professionals, researchers, athletes, and aesthetic specialists. Products are non-invasive, eye-safe, and anti-inflammatory. The company holds FDA 510(k) clearance (#K142256) and emphasizes patented technology developed by in-house medical experts.